Aronora, Inc. reposted this
🚀 Exciting news in cardiology and anticoagulants! A new class of anticoagulants targeting factor XI aims to prevent or reduce blood clots without increasing bleeding risks. NYBC Ventures is thrilled about our (not so) closely held portfolio company Aronora, Inc. involvement in this groundbreaking development. Factor XI inhibitors show promise in revolutionizing anticoagulation therapy, offering hope for improved patient outcomes. Stay tuned for updates as we follow the progress of this innovation! #Cardiology #Anticoagulants #Innovation #MedicalResearch https://lnkd.in/gurDEGkE
